enVVeno Medical Corporation
NVNO
$3.63
$0.010.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.55% | 7.22% | 11.68% | 18.08% | 14.05% |
| Total Depreciation and Amortization | -7.62% | -3.30% | -0.37% | 2.23% | 3.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.12% | -11.97% | -22.94% | -37.97% | -47.71% |
| Change in Net Operating Assets | -2,244.44% | 147.08% | -223.66% | -295.15% | 95.50% |
| Cash from Operations | -0.05% | 10.71% | 5.83% | 7.59% | 0.62% |
| Capital Expenditure | 28.95% | -12.12% | 2.63% | 36.73% | 25.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 151.61% | 117.52% | -148.99% | -183.89% | 73.24% |
| Cash from Investing | 151.07% | 116.98% | -149.27% | -184.42% | 73.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -47.40% | -47.12% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -47.40% | -47.12% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,419.51% | -99.57% | 532.33% | 46.42% | 100.08% |